News Posts List
NexMed to Present PrevOnco® Data at ILCA Annual Conference
06/30/2010
The presentation, entitled, PrevOnco® Exhibits In Vitro Cytolytic Activity, Prolongs Survival in Kidney Cancer and Leukemia Models and Reduces Tumor Growth Rates Alone and in Concert in a Liver Cancer Model, is scheduled to be presented by Bassam Damaj, Ph.D., President and Chief Executive Officer of NexMed, on Saturday, September 11, 2010 from 2:30 - 4:30 p.m.
Perifosine phase II clinical studies
06/30/2010
Perifosine is also in current multiple phase II clinical studies, including renal cell carcinoma.
PrevOnco Prolongs Survival in Kidney Cancer
06/29/2010
"PrevOnco(R) Exhibits In Vitro Cytolytic Activity, Prolongs Survival in Kidney Cancer and Leukemia Models and Reduces Tumor Growth Rates Alone and in Concert in a Liver Cancer Model"
IMA901 has completed a successful Phase II trial in renal cell carcinoma
06/29/2010
Scancell Holdings Plc, (PLUS:SCLP), the developer of therapeutic cancer vaccines, today announces a research collaboration with immatics biotechnologies GmbH ("immatics") to explore the development of novel ImmunoBody® vaccines.
Rob Fowler's Mustache Art Show
06/29/2010
Fowler survived kidney cancer a few years ago and shaved his infamous strip of hair to raise awareness . . .
Phase I Study of Single-Agent AntiProgrammed Death-1 (MDX-1106) in Refractory Solid Tumors
06/29/2010
Programmed death-1 (PD-1), an inhibitory receptor expressed on activated T cells, may suppress antitumor immunity. This phase I study sought to determine the safety and tolerability of antiPD-1 blockade in patients with treatment-refractory solid tumors and to preliminarily assess antitumor activity, pharmacodynamics, and immunologic correlates.
53-year-old fundraises for "life savers"
06/29/2010
Glynis Zimmerman, of Hamilton Street, Parkeston, was diagnosed with double kidney cancer last September.
Child cancer survivors have higher heart risk
06/29/2010
Children and young people who survive cancer have a significantly higher risk of developing heart disease as young adults because of the cancer treatment they received, researchers said . . .
Thalidomide has benefits
06/28/2010
Thalidomide is now FDA-approved for the treatment of multiple myeloma. It has also been used to treat myelofibrosis, Kaposi sarcoma, and renal cell cancer along with the pain of leprosy. Many more uses for thalidomide are under study. Thalidomide is dangerous only when used in the wrong patients.
Govt's. tardy response to BP oil catastrophe could destroy a major U.S. city
06/28/2010
Benzene has been connected to a rare form of kidney cancer in two separate studies, one involving tank truck drivers, and the other involving seamen on tanker vessels, both carrying benzene-laden chemicals.
News Feed